New Zealand markets open in 1 hour 56 minutes

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
127.79+3.56 (+2.87%)
As of 02:04PM EST. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    Novo Nordisk A/S - share repurchase programme

    Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 04 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period be

  • Investor's Business Daily

    How The Red-Hot Obesity Space Could Help Eli Lilly Join The 1,000 Club

    Lilly's new weight-loss drug could top $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000.

  • Investor's Business Daily

    Is Eli Lilly Stock A Buy On Projection For $81 Billion In Weight-Loss Sales?

    There's a growing field of competitors in the weight-loss drugs space, where Lilly and Novo currently dominate. Is Eli Lilly stock a buy?